This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Archived - Kang Da
- Starting date:
- January 5, 2007
- Posting date:
- January 5, 2007
- Type of communication:
- Foreign Product Alert (FPA)
- Subcategory:
- Natural health products
- Source of recall:
- Health Canada
- Issue:
- Product Safety, Undeclared Substance
- Audience:
- General Public
- Identification number:
- RA-12000123
These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.
Source of alert
New Zealand's Ministry of Health Medicines Safety Authority, Medsafe
Product name
One product is labelled as Kang Da and four products are unlabelled.
Manufacturer / Place of origin
Unknown / China
Product description
Kang Da is marketed as a sexual enhancement and erectile dysfunction product and comes in a package of two red capsules in a gold-foil blister.
The four unlabelled products come in various forms:
- four red/brown tablets marked "800mg" in a small plastic resealable zip-lock bag;
- bright green capsules in a small plastic zip-lock bag;
- an orange/black capsule in a clear plastic pack with red dots, and
- cream coloured capsules (one or two) in an orange, blue and clear plastic pack.
Reason for warning
On July 21, 2006, the New Zealand Ministry of Health issued a press release on Kang Da and four unlabelled products because these herbal products were adulterated with sildenafil (the generic name for Viagra), which is a prescription medication used in the treatment of erectile dysfunction. Sildenafil should only be taken under the guidance of a health care professional.
Possible side effects
Use of sildenafil may lead to serious health risks, especially for patients with existing medical conditions such as heart problems, who are taking heart medications, or who may be at risk for strokes.
Sildenafil has also been associated with serious side effects including sudden vision loss, penile tissue damage and urinary tract infection.
What you should do
Canadians who have this product are advised not to use it, and should consult with a health care professional if they have concerns about their health related to the use of this product.
Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-96755 if they find the product listed above in the Canadian marketplace.
Background
Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.
As of the date of this posting, no adverse reactions suspected to be associated with the use of this product have been reported in Canada.
Report a health or safety concern
- Call toll-free at 1-866-234-2345.
- Visit Health Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.
Media enquiries
Health Canada
613-957-2983
Public enquiries
613-957-2991
1-866-225-0709